NORD's
Washington Office
 Check here to read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.
|
|
|
|
NORD Events
NORD 20th Anniversary Gala
Monday, May 19, 2003
Capital Hilton Hotel, Washington, DC
To commemorate the 20th Anniversary of the Orphan Drug Act, the
National Organization for Rare Disorders, Inc. and two decades of dramatic progress
for the rare disease community, we will honor those who have made this possible:
The United States House of Representatives
The United States Senate
The U.S. Department of Health and Human Services
The Food and Drug Administration
The National Institutes of Health
(NIH Director, Dr. Elias Zerhouni will accept this Award)
And
The NORD 20-Year Achievement Award
to companies that have made significant achievements in Orphan Drug Development
in the past twenty years:
Amgen
Allergan, Inc.
Bayer
Bristol Myers
Genentech
Genzyme
Glaxo
Hoechst Marion Roussel (Aventis Pharmaceutical)
Hoffman-LaRoche
Immunex
MedImmune
Medtronic, Inc.
Mylan
Novartis
Orphan Medical
Pharmacia
Serono
Sigma-Tau Pharmaceuticals
Swedish Orphan International AB
Teva
|
|
|
|
Since 1983, working toward the prevention, treatment, and cure of rare
“orphan” diseases.
|
 Worth Magazine
named NORD one of America's top 100 charities. Make your donation and help 25 million Americans with rare disorders.
Tribute Banquet
NORD honors members of Congress, scientists, and pharmaceutical firms for advances in rare-disease therapies at its annual Tribute Banquet in Washington, DC.
[Go to Article]
|
